These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2784177)

  • 21. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
    Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
    Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Incidence of coronary disease and other metabolic diseases in 80 gout patients].
    Pianzola EL; Ulloa Lugo S; Robles Gil J
    Arch Inst Cardiol Mex; 1979; 49(1):25-33. PubMed ID: 434957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
    Onat A
    Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of major modifiable risk factors among patients with coronary artery disease--a retrospective analysis.
    Achari V; Thakur AK
    J Assoc Physicians India; 2004 Feb; 52():103-8. PubMed ID: 15656042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gout and hyperlipidaemia. Effect of overweight on the levels of circulating lipids.
    Rondier J; Truffert J; le Gô A; Cayla J; Hila A; de Gennes JL; Delbarre F
    Ann Clin Res; 1977 Aug; 9(4):239-45. PubMed ID: 616208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of benzbromarone on hyperlipidemia in gout].
    Marinchev L; Kŭnev K
    Vutr Boles; 1990; 29(5):99-102. PubMed ID: 2080622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperlipoproteinaemia in primary gout: hyperlipoproteinaemic phenotype and influence of alcohol intake and obesity in Japan.
    Jiao S; Kameda K; Matsuzawa Y; Tarui S
    Ann Rheum Dis; 1986 Apr; 45(4):308-13. PubMed ID: 3707219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observations concerning the incidence of disturbance of lipid and carbohydrate metabolism in gout.
    Frank O
    Adv Exp Med Biol; 1974; 41():495-8. PubMed ID: 4832573
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lipid metabolism in depressive syndromes with the symptoms of disorders of the cardiovascular and cerebrovascular systems during pharmacological treatment].
    Strzyzewski W; Szajnerman Z; Chłopocka-Woźniak M; Zelechowska-Ruda E; Jaracz J
    Psychiatr Pol; 1990; 24(6):32-40. PubMed ID: 2131481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A neutrophil signature is strongly associated with increased cardiovascular risk in gout.
    Vedder D; Gerritsen M; Nurmohamed MT; van Vollenhoven RF; Lood C
    Rheumatology (Oxford); 2021 Jun; 60(6):2783-2790. PubMed ID: 33188698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of IL-33 for Preventing the Kidney Injury via Regulating the Lipid Metabolism in Gout Patients.
    Duan L; Huang Y; Su Q; Lin Q; Liu W; Luo J; Yu B; He Y; Qian H; Liu Y; Chen J; Shi G
    J Diabetes Res; 2016; 2016():1028401. PubMed ID: 27579324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reappraisal of the role of the diabetic state in coronary artery disease.
    Hambly RI; Sherman L; Mehta J; Aintablian A
    Chest; 1976 Aug; 70(2):251-7. PubMed ID: 181212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triglycerides, cholesterol, and phospholipids in normal heart papillary muscle and in patients suffering from diabetes, cholelithiasis, hypertension, and coronary atheroma.
    Alavaikko M; Elfving R; Hirvonen J; Järvi J
    J Clin Pathol; 1973 Apr; 26(4):285-93. PubMed ID: 4267165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lipid changes in gout in comparison with degenerative rheumatism].
    Miko M; Degmecić M; Jajić I
    Reumatizam; 1978; 25(1):6-12. PubMed ID: 306123
    [No Abstract]   [Full Text] [Related]  

  • 35. [Primary gout and ischemic heart disease].
    Vukovic D; Vitic J; Nikolic V
    Srp Arh Celok Lek; 1975 Apr; 103(4):293-300. PubMed ID: 1162503
    [No Abstract]   [Full Text] [Related]  

  • 36. [Gout and atherosclerosis].
    Vukotić D; Pilipović N; Mircetić V
    Reumatizam; 1978; 25(4):111-6. PubMed ID: 694251
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple Beau's lines.
    Sweren RJ; Burnett JW
    Cutis; 1982 Jan; 29(1):41-2. PubMed ID: 7056066
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary gout in aging patients.
    Carcassi A; Boschi S; D'Ubaldo F; Campagna S
    Adv Exp Med Biol; 1986; 195 Pt A():329-32. PubMed ID: 3728163
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of gout.
    Klinefelter HF
    JAMA; 1977 Sep; 238(10):1025. PubMed ID: 577940
    [No Abstract]   [Full Text] [Related]  

  • 40. Above-normal concentrations of lipid peroxide in serum of patients with gout.
    Nishida Y; Kamatani N; Miyamoto T
    Clin Chem; 1984 Apr; 30(4):592-3. PubMed ID: 6705221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.